CEOCFO Magazine,
Phone: 727-480-7070

Email: info@ceocfocontact.com

Weekly Digital Publication IN-DEPTH INTERVIEWS WITH Top   CORPORATE EXECUTIVES (727) 480-7070 LF@CEOCFOMAIL.COM FIND INTERVIEWS AND ARTICLES

Business Services | Solutions

Health | Medical | Biotech

Cannabis  | Psychedelics

Banking | FinTech | Capital

Government Services

Public Companies

Industrial | Resources

Clean Tech

Global | Canadian



Lynn Fosse, Senior Editor

Steve Alexander, Associate Editor

Bud Wayne, Editorial Executive

Christy Rivers - Editorial Executive

Valerie Austin - Editorial Associate

INTERview


Print - PDF







Aliri Bio - Provides Growth-Class, Bioanalytical, and Spatial Biology Services to Drug Development Companies Worldwide


Kevin Jones

President


Aliri Bio




Interview conducted by:

Lynn Fosse, Senior Editor

CEOCFO Magazine


Published – December 15, 2025


CEOCFO: Mr. Jones, what is the idea behind Aliri Bio?

Mr. Jones: Aliri provides growth-class, bioanalytical, and spatial biology services to companies around the world doing drug development. That covers everything from discovery and the very early stages to toxicology, on into first in man, and then eventually into early and late-stage clinical testing.


We offer a full suite of services that include traditional bioanalytical testing services with toxicology and clinical support. In addition, our lab in France provides spatial biology services, which is where we do spatial imaging and biospectroscopy. We do biomarkers, translational work, and specialize in multi-omics, including metabolomics, proteomics and transcriptomics.


We like to offer a wide range of services for the customers that we support.


CEOCFO: What does world class service mean for Aliri?

Mr. Jones: For us, it means cutting-edge science. It means putting the customer first and always trying to keep their needs in mind. It is the flexibility we provide, because drug development today requires much more dynamic scheduling, flexibility, and delivery.


We pride ourselves on being first-in-class when it comes to data quality, study start and delivery timelines, and capacity. We deliver great quality and do so at a competitive price. That is what we believe world class is. We check all of those boxes for our customers.


CEOCFO: How do you keep up to date on new methods of testing?

Mr. Jones: It is a bit of a combination of things. We dedicate significant time to research and development, identifying market trends, and understanding customers need to be successful. Our scientists are long-tenured and passionate about innovation, always pushing the limits of what’s possible to achieve better results for our customers. We invest our own time and intellectual property to develop new methods, and work with our customers to help develop their methods. We have been leaders in the bioanalysis industry for 30 years and maintain a rigorous practice of continuous evaluation and improvement of all of our services.


CEOCFO: Would you tell how AI comes into play and how you are able to take advantage of that for your customers?

Mr. Jones: The data is just the beginning of what we are delivering to the customer; it then must be collated, interpreted, and distilled to gain actionable insights. That is where AI comes into play. Our proprietary algorithms allow us to translate our clients’ data to gain insights that help solve the questions that they have about their molecule’s safety and efficacy.


Instead of reporting the data and walking away, AI allows us to provide more insightful answers to the customer, in a much more concise and digestible format. This is a customized approach that varies from project to project, and we see significant benefits when combining AI with our spatial-omics services to predict patient outcomes. This allows our customers to anticipate potential challenges, years in advance.


CEOCFO: You mentioned a bit about your interactions with customers; what do you do that is different from other labs?

Mr. Jones: One thing that makes us different from other labs is the time we spend getting to know our customers’ challenges. We listen and understand what they are looking for, and understand the dynamic nature of drug development. We work closely with our customers to understand their needs, whether it is speed, scientific expertise, capacity, or a collaborative partner to help them develop their method. It is all about being flexible and solving their problems.


Our scientists in the lab are highly accessible to our customers to answer questions and advise on the right bioanalytical approach for their molecule. I think this is very unique. In our industry, it is rare that all customers, especially smaller biotech companies, are treated with the same level of care as large pharmaceutical companies. Our customers are actually able to speak directly with the scientists that are working on their project. That provides a lot of confidence, a lot of credibility, and ownership between the two parties.


CEOCFO: Are companies turning to you because they recognize the depth of how you work with them, or are they surprised at the level of care you provide throughout your engagement?

Mr. Jones: I think it is a bit of both. A large part of our customer base is repeat customers, and I believe it is because they get that one-on-one experience and direct interaction with our lab scientists and scientific leaders. Drug developers value the opportunity to sit down and talk about the issues they are having in the laboratory and to engage with our scientists as they design the experiments that will be run. They welcome that. I think a lot of customers come back to us because of their previous experience working with our team.


New customers may not be aware of the level of care we take in this area, but in those cases, we make sure that they experience that strong partnership and understand that our scientists are only one call away. This gives them confidence that we are the right lab to deliver the results they are looking for.


CEOCFO: Aliri is a combination of three laboratories. How does that work out for your customers?

Mr. Jones: Thank you for asking that. We focus on an internal strategy of “One Aliri.” We have invested time and effort in the harmonization of our processes globally. This includes our operational excellence processes so that a customer gets the same experience every time, whether the data is being run in Salt Lake City, Colorado Springs, or in France.


The “One Aliri” mantra is something that we live by and enforce in our labs daily to make sure that the experience for the customer is consistent. For our employees, we make sure that across all sites, the systems, processes and tools they use are similar, if not identical, to make sure that cross-site communication is seamless, and that employees can all do their jobs the most efficient way possible. When you have the harmonized processes, the culture of accountability, good communication, and putting the customer first, the experience for the customer will be excellent.


CEOCFO: How do you spend your day as president of Aliri?

Mr. Jones: Lots of meetings. My time is spent making sure that all the “trains” are coming in and going out of the “station” when and how they are supposed to. I set the strategy of where we are going for the future and oversee execution to ensure customer data is being delivered on time and prioritize being available for both our team members and customers when they need support. I also make sure that our stakeholders are getting the feedback that they need and that we are managing our business cost-effectively to get good returns on our investments.


There is a fair amount of time I spend in meetings with the staff, coaching, mentoring, and helping to develop the leaders of the future. No two days are ever the same. It depends on where we are at a given month or given quarter as to where my time is spent. I like to view it as a good combination of strategy, tactics, and looking to the future, but also making sure we are delivering for today and that everyone is getting the support that they need. It is my job to make sure that all of that is getting taken care of on a day-to-day basis.


CEOCFO: How do you support your employees?

Mr. Jones: We try to make sure that their voices are heard. We have something internally called the Aliri Pulse, which is an engagement council made up of members of staff from across all Aliri’s sites. The group meets monthly with members of the human resource team and I, and we go over different topics such as communication, employee engagement, social activities, and perhaps tools that people feel we need. We try to keep that constant channel of communication back and forth.


We don’t wait for an engagement or a problem or an issue to arise. Employees have a direct channel to me as the head of the organization and are encouraged to provide feedback as needed so we can course correct and continue improving.


This allows me to address questions that I otherwise might not have heard. I think this has worked out well for us, and it is something I will continue doing in the future.


CEOCFO: How do you reach out to potential new customers as well as people coming back?

Mr. Jones: We use a couple of different pathways. It is all about relationship management, especially by our frontline study directors, which we call Principle Analytical Investigators, who are interacting with customers on a day-to-day basis. Our commercial team also forms strong relationships with our customers and checks in on them periodically to make sure their needs are being met. We also have routine project meetings during the time projects are live, where the scientists, commercial, and lab management teams come together to do a collective touchpoint.


I travel quite a bit with the sales team to meet customers on-site at their facilities, where I have the opportunity to thank them personally for the work that they have provided us with. Other members of my leadership team do the same thing. I have various site leaders who meet with our customers outside of the lab to hear their feedback firsthand.


CEOCFO: What is the takeaway for our readers; why choose Aliri Bio?

Mr. Jones: Why Aliri? We are great scientists. We care about our customers and prioritize excellence in everything that we do. We have brought three great companies together under the Aliri brand and embody the best of each of those entities, with our depth and breadth of science, our excellent people, our communication practices, and our extensive regulatory experience. We can leave customers with a very positive experience: fast study set up and startups, quick execution on projects, good quality delivery, and strong communication throughout the project lifecycle. Those are the key things that people are looking for.


Our customers need service providers that they can depend on and trust with their molecules, and they know that we are going to deliver for them, because we have a history of doing just that. That is what I think makes a difference at Aliri.

Aliri Bio | Kevin Jones | Aliri Bio - Provides Growth-Class, Bioanalytical, and Spatial Biology Services to Drug Development Companies Worldwide | CEO Interviews 2025 | Medical Companies


“Our scientists in the lab are highly accessible to our customers to answer questions and advise on the right bioanalytical approach for their molecule. I think this is very unique. In our industry, it is rare that all customers, especially smaller biotech companies, are treated with the same level of care as large pharmaceutical companies. Our customers are actually able to speak directly with the scientists that are working on their project. That provides a lot of confidence, a lot of credibility, and ownership between the two parties.”

Kevin Jones


HOME

CURRENT ISSUE

INTERVIEW INDEX

CEOCFO SERVICES

CEOCFO MOBILE